Skip to main content

Advertisement

Log in

Influence of bisphosphonates on the adherence and metabolism of epithelial cells and gingival fibroblasts to titanium surfaces

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Objectives

To evaluate the effects of sodium alendronate (SA) and zoledronic acid (ZA), on the adhesion and metabolism of epithelial cells and gingival fibroblasts to titanium surfaces considering cell functions related to an effective mucosal barrier around the implant.

Materials and methods

Cells were seeded onto titanium discs and incubated for 24 h. Then, serum-free DMEM containing selected bisphosphonates (0, 0.5, 1, or 5 μM) was added for 24 and 48 h. Factors related to the achievement of an effective mechanical and immunological barrier—cell adhesion, viability, collagen epidermal growth factor, and immunoglobulin synthesis—were evaluated. Data were analyzed by Kruskal-Wallis and Mann-Whitney tests as well as by ANOVA and Tukey’s tests, (α = 0.05).

Results

The presence of bisphosphonates culminated in lower cell adhesion to the titanium discs, particularly for SA at 5 μM (40%) and ZA at all concentrations (from 30 to 50%, according to increased concentrations). Reduced cell viability occurred after exposing these cells to ZA (40%); however, only 5 μM SA-treated cells had decreased viability (30%). Reduced synthesis of growth factors and collagen was observed when cells were reated with ZA (20 and 40%, respectively), while about 70% of IgG synthesis was enhanced.

Conclusion

Bisphosphonates negatively affected the adhesion and metabolism of oral mucosal cells, and this effect was related to the type of bisphosphonate as well as to concentration and period of treatment.

Clinical relevance

The negative effects of bisphosphonates on oral mucosal cells can hamper the formation of an effective biological seal in osseointegrated implants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Rogers MJ, Gordon S, Benford HL et al (2000) Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88:2961–2978

    Article  PubMed  Google Scholar 

  2. Russell RG (2011) Bisphosphonates: the first 40 years. Bone 49:2–19

    Article  PubMed  Google Scholar 

  3. Simon MJK, Niehoff P, Kimming B, Açil Y (2010) Expression profile and synthesis of different collagen types I, II, III and V of human gingiva fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment. Clin Oral Invest 14:51–58

    Article  Google Scholar 

  4. Walter C, Klein MO, Pabst A, Al-Nawas B, Duschner H, Ziebart T (2010) Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells. Clin Oral Invest 14:35–41

    Article  Google Scholar 

  5. Basso FG, Pansani TN, Oliveira CF et al (2013) Cytotoxic effects of zoledronic acid on human epithelial cells and gingival fibroblasts. Braz Dent J 24:551–558

    Article  PubMed  Google Scholar 

  6. Basso FG, Turrioni APS, Hebling J, de Souza Costa CA (2013) Zoledronic acid inhibits human osteoblast activities. Gerontology 59:534–541

    Article  PubMed  Google Scholar 

  7. Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo S (2005) Managing the care of patients with bisphosphonate-associated osteonecrosis. JADA 136:1658–1668

    PubMed  Google Scholar 

  8. Woo S, Hellstein JW, Kalmar JR (2006) Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753–761

    Article  PubMed  Google Scholar 

  9. Diel IJ, Fogelman I, Al-Nawas B et al (2007) Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: is there a diverse relationship of amino and non-aminobisphosphonates? Crit Rev Oncol Hematol 64:198–207

    Article  PubMed  Google Scholar 

  10. Idris AI, Rojas J, Greis IR, van’t Hof RJ, Ralston SH (2008) Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro. Calcif Tissue Int 82:191–201

    Article  PubMed  Google Scholar 

  11. Orriss IR, Key ML, Colston KW, Arnett TR (2008) Inhibition of osteoblast function in vitro by aminobisphosphonates. J Cell Biochem 106:109–118

    Article  Google Scholar 

  12. Scheper MA, Badros A, Salama AR et al (2009) A novel bioassay model to determine clinically significant bisphosphonate levels. Support Care Cancer 17:1553–1557

    Article  PubMed  Google Scholar 

  13. Ravosa MJ, Ning J, Liu Y, Stack S (2011) Bisphosphonate effects on the behavior of oral epithelial cells and oral fibroblasts. Arch Oral Biol 56:491–498

    Article  PubMed  Google Scholar 

  14. Basso FG, Turrioni APS, Soares DG, Bagnato VS, Hebling J, de Souza Costa CA (2014) Low-level laser therapy for osteonecrotic lesions: effects on osteoblasts treated with zoledronic acid. Support Care Cancer 22:2741–2748

    Article  PubMed  Google Scholar 

  15. Migliorati CA, Woo S, Hewson I et al (2009) A systematic review of bisphosphonate osteonecroses (BON) in cancer. Support Care Cancer 18:1099–1106

    Article  Google Scholar 

  16. Landesberg R, Woo V, Cremers S et al (2011) Potential pathophysiological mechanism in osteonecroses of the jaw. Ann N Y Acad Sci 1218:62–69

    Article  PubMed  PubMed Central  Google Scholar 

  17. Reid IR (2009) Osteonecrosis of the jaw—who gets it and why? Bone 44:4–10

    Article  PubMed  Google Scholar 

  18. Otto S, Pautke C, Opelz C et al (2010) Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism. J Oral Maxillofac Surg 68:2837–2845

    Article  PubMed  Google Scholar 

  19. Madrid C, Sanz M (2009) What impact do systemically administered bisphosphonates have on oral implant therapy? A systematic review. Clin Oral Impl Res 20:87–95

    Article  Google Scholar 

  20. Javed F, Almas K (2010) Osseointegration of dental implants in patients undergoing bisphosphonate treatment: a literature review. J Periodontol 81:479–484

    Article  PubMed  Google Scholar 

  21. Chadha G, Ahmadieh A, Kumar S, Sedghzadeh PP (2013) Osseointegration of dental implants and osteonecrosis of the jaw in patients treated with bisphosphonate therapy: a systematic review. J Oral Implantol 39:510–520

    Article  PubMed  Google Scholar 

  22. Taxel P, Ortiz D, Shafer D et al (2014) The relationship between implant stability and bone health markers in post-menopausal women with bisphosphonate exposure. Clin Oral Invest 18:49–57

    Article  Google Scholar 

  23. An N, Rausch-fan X, Wieland M, Matejka M, Andrukhov O, Schedle A (2012) Initial attachment, subsequent cell proliferation/viability and gene expression of epithelial cells related to attachment and wound healing in response to different titanium surfaces. Dent Mater 28:1207–1214

    Article  PubMed  Google Scholar 

  24. Etminan M, Aminzadeh K, Mathew IR, Brophy JM (2008) Use of oral bisphosphonates and risk of aseptic osteonecrosis: a nested case-control study. J Rheumatol 35:691–695

    PubMed  Google Scholar 

  25. Khan AA, Sándor GK, Dore E et al (2008) Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol 35:1391–1397

    PubMed  Google Scholar 

  26. Bedogni A, Bettini G, Totola A, Saia G, Nocini PF (2010) Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgey: a case report and literature review. J Oral Maxillofac Surg 68:1662–1666

    Article  PubMed  Google Scholar 

  27. Assael LA (2009) Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. J Oral Maxillofac Surg 67:35–43

    Article  PubMed  Google Scholar 

  28. Body JJ, Mancini I (2002) Bisphosphonates for cancer patients: why, how, and when? Support Care Cancer 10:399–407

    Article  PubMed  Google Scholar 

  29. Hynes RO (1992) Integrins: versatility, modulation and signaling in cell adhesion. Cell 69:11–25

    Article  PubMed  Google Scholar 

  30. Patidar K, Parwani RN, Wanjari SP (2011) Correlation of salivary and serum IgG, IgA levels wih total protein in oral submucous fibrosis. J Oral Sci 53:97–102

    Article  PubMed  Google Scholar 

  31. Tilakaratne WM, Klinikowki MF, Saku T, Peters TJ, Warnakulasuriya S (2006) Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 42:561–568

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Authors acknowledge the National Council for Scientific and Technological Development – CNPq (Grants: 157779/2015-7, 442637/2014-4, 303599/2014, 307696/2014) for the financial suport.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fernanda Gonçalves Basso.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Funding

The work was supported by the National Council for Scientific and Technological Development – CNPq (Grants: 157779/2015-7, 442637/2014-4, 303599/2014, 307696/2014).

Ethical approval

All procedures were performed in accordance to Ethics Committee of Araraquara School of Dentistry, Unesp, Brazil.

Informed consent

Gingival fibroblasts were isolated after patients agreement by signing of informed consent.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Basso, F.G., Pansani, T.N., Soares, D.G. et al. Influence of bisphosphonates on the adherence and metabolism of epithelial cells and gingival fibroblasts to titanium surfaces. Clin Oral Invest 22, 893–900 (2018). https://doi.org/10.1007/s00784-017-2167-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-017-2167-2

Keywords

Navigation